Microglia are brain-resident macrophages playing pivotal roles in CNS development and homeostasis. Yet, the cellular and molecular basis governing microglia maintenance ...

Johnson & Johnson has moved a step closer to filing a potential first-in-class therapy for psoriasis after the drug hit the mark in a phase 3 trial. Once-daily oral IL-23 inhibitor icotrokinra (fo ...

Prism Johnson Ltd., incorporated in the year 1992, is a Mid Cap company (having a market cap of Rs 6,384.57 Crore) operating in Cement sector. Prism Johnson Ltd. key Products/Revenue Segments include ...

New Zealand's High Court has cleared the three owners of liability for deaths and harm from a 2019 eruption.